3D- quantitative structure-activity relationship analysis of some 2-substituted halogenbenzimidazoles analogues with antimycobacterial activity

International Journal of ChemTech Research

Volumn 2, Issue 1, 2010, Pages 606-614

  Sharma, M C ^a   Sharma, Smita ^b  

^a DEVI AHILYA UNIVERSITY   (India)

^b Department of Chemistry ^*  (India)

Author keywords

3DQSAR; Halogenbenzimidazoles; kNN; Method antimycobacterial

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BENZIMIDAZOLE DERIVATIVE; HALOCARBON;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; ELECTRICITY; K NEAREST NEIGHBOR; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOSPECIFICITY; SURFACE PROPERTY; VALIDATION PROCESS;

EID: 77953372657     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Snider D.E.,Raviglione M., Kochi A., in B. Bloom (Ed.), Tuberculosis Pathogenesis, Protection and Control: Global Burden of Tuberculosis. ASM Press, Washington, DC, 1994, 3.
2. Ballell L., Field R.A., Duncan.K., Young R.J., Antimicrob. Agents Chemother. 2005, (6) 49, 2153-2163.
3. (a). Neu H.C., Science 1992,257, 1064-1072
4. (b) Spigelman M.K., New tuberculosis therapeutics a growing pipeline, J. Infect. Dis. 2007, 196,828-834.
5. st century, Infect. Dis. Clin. North Am. 2002,161, 1-58.
6. Walczak K., Gondela A., Suwinski J., Eur. J. Med. Chem. 2004,39,849-853
7. (a) Babaoglu K., Page M.A., V.C. Jones, McNeil M.R., Dong C.,. Naismith J.H.,. Lee R.E., Bioorg. Med. Chem. Lett.2003,13 (19) 3227-3230.
8. (b) Shiradkar M.R., Murahari K.K., Gangadasu H.R., Suresh T., Kalyan C.A., Panchal D., Kaur R., Burange P., Ghogare J., Mokale V., Raut M., Bioorg. Med. Chem. Lett. 2007 ,15,3997-4008.
9. (a) Shiradkar M.R., Bhandari S.V., Kale R.P., Laghate A., Rathi A.Asian J. Chem. 2006,18 (4) 2700-2704.
10. (b) Shiradkar M.R., Gorentia Venkata S., Dasari V., Tatikonda S., Akula K.C, Shah R., Eur. J. Med. Chem. 2007, 42 (6) ,807-816;
11. Kazimierczuk., Andrzejewska M., Kaustova J.,Klimesova V., Eur. J. Med. Chem. 2005, 40,203-208.
12. .Cramer R. D.,. Patterson D. E, Bunce J. D.J. Am. Chem. Soc., 1988,110, 5959.
13. Klebe G., Abraham U., Mietzner T., J. Med. Chem., 1994,37,24.
14. Baroni M., Costantino G., Cruciani G., Riganelli D., Valigi R., Clementi S., An Advanced Chemometric Tool for Handling 3D-QSAR Problems, Quant. Struct.-Act. Relat., 1993,12, 9.
15. Cho S. J., and Tropsha A., J. Med. Chem., 1995,38, 1060.
16. V-life MDS 3.0 vlife science technologies pvt.Ltd,1 akshay residency, plot 50, Anand park, Aundh, Pune- 411007
17. Chakraborti A.K., Gopalakrishnan B.,. Sobhia M.E, Malde A., Eur. J. Med. Chem. 2003,38, 975-982.
18. W.H.O Report Global Tuberculosis Control, Surveillance, planning, Financing, Geneva, 2004.
19. .Coi A.,. Fiamingo F.L, Livi O., Bioorg. Med. Chem. 2009,17, 319-325.
20. .Golbraikh A., Tropsha A., J. Comp. Aid. Molec. Des. 200216, 357-369.
21. Golbraikh A., J. Chem. Inf. Comput.Sci. 2000,40, 414-425.
22. Guha R., Serra J.R., Jurs P.C., J. Mol. Graph. Model 2004, 23, 1-14.
23. Golbraikh A. and Tropsha A., J. Chem. Inf. Comput. Sci., 200343, 144
24. Sharaf M. A., Illman D. L., Kowalski B. R., Chemometrics, Wiley, New York, 1986.
25. J. Holland, Adaptation in Natural and Artificial Systems, University of Michigan Press, 1975.